Identification and Experimental Validation of Parkinson's Disease with Major Depressive Disorder Common Genes

被引:3
|
作者
Wang, Huiqing [1 ]
Dou, Shanshan [2 ]
Wang, Chunmei [3 ]
Gao, Wenming [2 ]
Cheng, Baohua [2 ,3 ]
Yan, Fuling [4 ]
机构
[1] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China
[2] Jining Med Univ, Coll Basic Med, Jining 272067, Peoples R China
[3] Jining Med Univ, Neurobiol Inst, Jining 272067, Peoples R China
[4] Southeast Univ, Affiliated ZhongDa Hosp, Sch Med, Dept Neurol, 87 Dingjiaqiao Rd, Nanjing 210009, Peoples R China
关键词
Parkinson's disease; Major depressive disorder; Neutrophil; Immune process; Bioinformatics; AQUAPORIN WATER CHANNELS; RABPHILIN; 3A; EXPRESSION; SYMPTOMS; MODEL; GEO;
D O I
10.1007/s12035-023-03451-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disease that affects about 10 million people worldwide. Non-motor and motor symptoms usually accompany PD. Major depressive disorder (MDD) is one of the non-motor manifestations of PD it remains unrecognized and undertreated effectively. MDD in PD has complicated pathophysiologies and remains unclear. The study aimed to explore the candidate genes and molecular mechanisms of PD with MDD. PD (GSE6613) and MDD (GSE98793) gene expression profiles were downloaded from Gene Expression Omnibus (GEO). Above all, the data of the two datasets were standardized separately, and differentially expressed genes (DEGs) were obtained by using the Limma package of R. Take the intersection of the two differential genes and remove the genes with inconsistent expression trends. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were investigated to explore the function of the common DEGs. Additionally, the construction of the protein-protein interaction (PPI) network was to search the hub genes, and then the least absolute shrinkage and selection operator (LASSO) regression was used to further identify the key genes. GSE99039 for PD and GSE201332 for MDD were performed to validate the hub genes by the violin plot and receiver operating characteristic (ROC) curve. Last but not least, immune cell dysregulation in PD was investigated by immune cell infiltration. As a result, a total of 45 common genes with the same trend. Functional analysis revealed that they were enriched in neutrophil degranulation, secretory granule membrane, and leukocyte activation. LASSO was performed on 8 candidate hub genes after CytoHubba filtered 14 node genes. Finally, AQP9, SPI1, and RPH3A were validated by GSE99039 and GSE201332. Additionally, the three genes were also detected by the qPCR in vivo model and all increased compared to the control. The co-occurrence of PD and MDD can be attributed to AQP9, SPI1, and RPH3A genes. Neutrophils and monocyte infiltration play important roles in the development of PD and MDD. Novel insights may be gained from the findings for the study of mechanisms.
引用
收藏
页码:6092 / 6108
页数:17
相关论文
共 50 条
  • [1] Identification and Experimental Validation of Parkinson’s Disease with Major Depressive Disorder Common Genes
    Huiqing Wang
    Shanshan Dou
    Chunmei Wang
    Wenming Gao
    Baohua Cheng
    Fuling Yan
    Molecular Neurobiology, 2023, 60 : 6092 - 6108
  • [2] Identification of Hub Genes Related to Alzheimer's Disease and Major Depressive Disorder
    Cheng, Yajing
    Sun, Meiyue
    Wang, Feng
    Geng, Xin
    Wang, Fei
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2021, 36
  • [3] Depression and Major Depressive Disorder in Patients with Parkinson's Disease
    Inoue, Takeshi
    Kitagawa, Mayumi
    Tanaka, Teruaki
    Nakagawa, Shin
    Koyama, Tsukasa
    MOVEMENT DISORDERS, 2010, 25 (01) : 44 - 49
  • [4] Depressive symptom pattern among Parkinson's disease patients with major depressive disorder
    Farabaugh, AH
    Locascio, J
    Yap, L
    Growdon, J
    Graves, L
    Fava, M
    MOVEMENT DISORDERS, 2006, 21 : S98 - S98
  • [5] Major depressive disorder in Parkinson's disease: a register-based study
    Nilsson, FM
    Kessing, LV
    Sorensen, TM
    Andersen, PK
    Bolwig, TG
    ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (03) : 202 - 211
  • [6] Efficacy and tolerability of bupropion in major depressive disorder associated with Parkinson's disease
    Vasile, D.
    Macovei, R. A.
    Vasiliu, O.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S322 - S323
  • [7] Agomelatine Treatment of Major Depressive Disorder in Parkinson's Disease: A Case Series
    De Berardis, Domenico
    Fornaro, Michele
    Serroni, Nicola
    Olivieri, Luigi
    Marini, Stefano
    Moschetta, Francesco Saverio
    Srinivasan, Venkataramanujam
    Assetta, Maurizio
    Valchera, Alessandro
    Salone, Anatolia
    Martinotti, Giovanni
    Onofrj, Marco
    Di Giannantonio, Massimo
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (04) : 343 - 345
  • [8] Identification and validation of senescence-related genes in Parkinson's disease
    Huang, Qi
    Zhao, Yingqian
    Wang, Yuan
    Qiao, Haifa
    Xu, Ziwen
    Meng, Jing
    Wu, Qiaozhen
    Zhou, Feng
    Wang, Qiang
    HUMAN GENE, 2024, 39
  • [9] Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder
    Zheng, Peng
    Wang, Ying
    Chen, Liang
    Yang, Deyu
    Meng, Huaqing
    Zhou, Dezhi
    Zhong, Jiaju
    Lei, Yang
    Melgiri, N. D.
    Xie, Peng
    MOLECULAR & CELLULAR PROTEOMICS, 2013, 12 (01) : 207 - 214
  • [10] Identification of necroptosis-related genes in Parkinson's disease by integrated bioinformatics analysis and experimental validation
    Cheng, Lei
    Zhou, Zhongyan
    Shi, Wenting
    Zhang, Jing
    Qin, Liyun
    Hu, Hongyi
    Yan, Juntao
    Ye, Qing
    FRONTIERS IN NEUROSCIENCE, 2023, 17